Bortezomib Completed Phase 2 Trials for Renal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00017329PS-341 in Treating Patients With Metastatic Kidney Cancer
NCT00025376PS-341 in Treating Patients With Metastatic Kidney Cancer
NCT00276614Bortezomib in Treating Patients With Metastatic Kidney Cancer